PGR and neoplasm: The field theory predicts that biomarkers of risk/causation would precede transformation to malignancy, whereas biomarkers of advanced tumor progression, e.g. changes in chromosomes, estrogen and progesterone receptors, and HER2/neu status, would follow transformation to malignancy.